Growing 3D human skin models, researchers are discovering what messaging occurs in healthy skin to try to understand what goes wrong in disease states.
Meghan Bliss-Moreau, a fourth-year PhD candidate in Northwestern University’s Driskill Graduate Program in Life Sciences, develops therapeutics for cancer in the lab of Steven Rosen.
Published in Nature Medicine, investigators have combined two hormones that hold the potential for a new treatment option.
Tiny regulators produced by one of seven human cancer viruses may be the key to understanding the most common AIDS-associated malignancy.
Northwestern’s Center for Device Development is bringing together clinicians and engineers to develop medical devices with guidance from entrepreneurial experts and through a series of real-world experiences.
New Northwestern Medicine research is believed to have uncovered a novel therapeutic target for the number one genetic killer of toddlers in the developed world. Yong-Chao Ma, PhD, assistant professor in pediatrics, neurology, and physiology, is also working to uncover the potential of a new target in the fight against Parkinson’s disease.
Started by Dean Eric G. Neilson, MD, the annual luncheon celebrating Feinberg’s endowed professors serves as a way to thank and honor these faculty members for their accomplishments and contributions to science, education, and research.
Jonathan Chou, a third-year medical student, received a $30,000 grant from Research to Prevent Blindness that will enable him to take a year off from medical school to study the deterioration of eyesight in diabetics.
An innovative year-long pilot program has laid the foundation for training focused on elevating community-engaged research teams to the level of National Institutes of Health funding.